PEGORARO, ELENA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 25.383
AS - Asia 7.768
EU - Europa 6.398
SA - Sud America 1.682
AF - Africa 1.489
OC - Oceania 178
Continente sconosciuto - Info sul continente non disponibili 82
Totale 42.980
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 24.476
SG - Singapore 2.548
HK - Hong Kong 1.552
CN - Cina 1.549
BR - Brasile 1.164
IT - Italia 1.111
FI - Finlandia 660
DE - Germania 659
SE - Svezia 574
VN - Vietnam 435
PL - Polonia 403
FR - Francia 355
UA - Ucraina 348
GB - Regno Unito 325
RU - Federazione Russa 295
NL - Olanda 196
AT - Austria 151
IE - Irlanda 140
IN - India 125
TR - Turchia 111
AR - Argentina 91
CA - Canada 88
KR - Corea 86
ZA - Sudafrica 81
MX - Messico 77
ES - Italia 72
JP - Giappone 64
SA - Arabia Saudita 64
CH - Svizzera 63
BE - Belgio 62
CO - Colombia 61
CZ - Repubblica Ceca 61
EC - Ecuador 58
IQ - Iraq 58
PY - Paraguay 58
LB - Libano 55
NO - Norvegia 54
PE - Perù 52
PA - Panama 51
GR - Grecia 50
RS - Serbia 50
AL - Albania 49
AO - Angola 49
NI - Nicaragua 49
NP - Nepal 49
BA - Bosnia-Erzegovina 48
CI - Costa d'Avorio 48
JO - Giordania 48
PH - Filippine 48
SI - Slovenia 48
AE - Emirati Arabi Uniti 47
EG - Egitto 47
GT - Guatemala 47
MY - Malesia 47
PK - Pakistan 47
AZ - Azerbaigian 46
CY - Cipro 46
DO - Repubblica Dominicana 46
HN - Honduras 46
MA - Marocco 46
BZ - Belize 45
ID - Indonesia 45
KZ - Kazakistan 45
LV - Lettonia 45
LY - Libia 45
TW - Taiwan 45
VE - Venezuela 45
CW - ???statistics.table.value.countryCode.CW??? 44
IL - Israele 44
KE - Kenya 44
TT - Trinidad e Tobago 44
UZ - Uzbekistan 44
CR - Costa Rica 43
DK - Danimarca 43
HU - Ungheria 43
RO - Romania 43
TN - Tunisia 43
DZ - Algeria 42
IS - Islanda 42
LC - Santa Lucia 42
ML - Mali 42
PT - Portogallo 42
RE - Reunion 42
BB - Barbados 41
KG - Kirghizistan 41
KH - Cambogia 41
BW - Botswana 40
BY - Bielorussia 40
CU - Cuba 40
JM - Giamaica 40
ME - Montenegro 40
TH - Thailandia 40
TJ - Tagikistan 40
ZM - Zambia 40
AM - Armenia 39
CL - Cile 39
GE - Georgia 39
MN - Mongolia 39
BS - Bahamas 38
CV - Capo Verde 38
Totale 41.111
Salva come PNG Salva come JPEG
Città #
Fairfield 3.684
Woodbridge 2.328
Houston 2.019
Ashburn 1.895
Ann Arbor 1.666
Hong Kong 1.522
Singapore 1.446
Chandler 1.419
Seattle 1.315
Jacksonville 1.252
Wilmington 1.244
Cambridge 1.228
Boardman 671
Princeton 541
San Diego 484
Beijing 419
Santa Clara 361
Medford 334
Bytom 327
Roxbury 325
Padova 251
Dong Ket 234
Des Moines 229
Helsinki 226
Nanjing 198
Munich 154
New York 127
Nuremberg 126
Milan 120
Dublin 118
Los Angeles 114
Hefei 92
Guangzhou 91
São Paulo 82
Shenyang 79
London 74
Vienna 68
Ho Chi Minh City 67
Hebei 64
Nanchang 57
Turku 57
Norwalk 52
Chicago 51
Buffalo 49
Managua 48
Ogden 48
Seoul 48
Amman 47
Lappeenranta 46
Luanda 46
Panama City 45
Rio de Janeiro 44
Baku 43
Brooklyn 43
Abidjan 42
Johannesburg 42
Castries 41
Jiaxing 41
Riga 41
Hanoi 40
Lusaka 40
Tianjin 40
Willemstad 40
Bamako 39
Bishkek 39
Bridgetown 39
Nairobi 39
Tashkent 39
Dushanbe 38
Shanghai 37
Ulan Bator 37
Nassau 36
Podgorica 36
Tokyo 36
Rome 35
San José 35
Conakry 34
Djibouti 34
Kampala 34
Noumea 34
Changsha 33
Lima 33
Phnom Penh 33
Phoenix 33
Warsaw 33
Antananarivo 32
Guatemala City 32
Havana 32
Reykjavik 32
Istanbul 31
Jinan 31
Libreville 31
Papeete 31
Tripoli 31
Vientiane 31
Accra 30
Cotonou 30
Dakar 30
Ljubljana 30
Montevideo 30
Totale 29.335
Salva come PNG Salva come JPEG
Nome #
Non-neural phenotype of spinal and bulbar muscular atrophy: Results from a large cohort of Italian patients 242
"Mitochondrial neuropathies": A survey from the large cohort of the Italian Network 240
SPP1 genotype and glucocorticoid treatment modify osteopontin expression in Duchenne muscular dystrophy cells 217
Increased mitophagy in the skeletal muscle of spinal and bulbar muscular atrophy patients 212
Specific numerical processing impairment in ALS patients 206
Unimpaired Neuropsychological Performance and Enhanced Memory Recall in Patients with Sbma: A Large Sample Comparative Study. 206
Polyglutamine-Expanded Androgen Receptor Alteration of Skeletal Muscle Homeostasis and Myonuclear Aggregation Are Affected by Sex, Age and Muscle Metabolism 188
A novel SACS mutation results in non-ataxic spastic paraplegia and peripheral neuropathy. 186
Improving the knowledge of amyotrophic lateral sclerosis genetics: novel SOD1 and FUS variants. 186
Muscle MRI and functional outcome measures in Becker muscular dystrophy 181
Comparison of muscle ultrastructure in myasthenia gravis with anti-MuSK and anti-AChR antibodies 180
Parkinson-like features in ALS with predominant upper motor neuron involvement 177
Health-related quality of life and functional changes in DMD:A 12-month longitudinal cohort study 177
Cardiomyopathy in patients with POMT1-related congenital and limb-girdle muscular dystrophy. 176
Functional changes in Becker muscular dystrophy: Implications for clinical trials in dystrophinopathies 176
Pachymeningeal involvement in POEMS syndrome: MRI and histopathological study. 173
Brain involvement in myotonic dystrophies: neuroimaging and neuropsychological comparative study in DM1 and DM2 172
Progress in enzyme replacement therapy in glycogen storage disease type II 171
null 171
ALS risk but not phenotype is affected by ataxin-2 intermediate length polyglutamine expansion 169
Reliable and versatile immortal muscle cell models from healthy and myotonic dystrophy type 1 primary human myoblasts 169
New FIG4 gene mutations causing aggressive ALS 165
TGFB2R but not SPP1 genotype modulates osteopontin expression in Duchenne muscular dystrophy muscle. 163
Genetic modifiers of Duchenne muscular dystrophy and dilated cardiomyopathy 163
Italian version of the Rasch-Built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS): validation and longitudinal performance 160
Genetic modifiers of respiratory function in Duchenne muscular dystrophy 160
Muscle MRI in patients with dysferlinopathy: Pattern recognition and implications for clinical trials 159
Elevated TGF β2 serum levels in Emery-Dreifuss Muscular Dystrophy: Implications for myocyte and tenocyte differentiation and fibrogenic processes 159
Abnormal cochlear potentials in Friedreich's ataxia point to disordered synchrony of auditory nerve fiber activity 158
Diagnostic and Prognostic Biomarkers in Amyotrophic Lateral Sclerosis: Neurofilament Light Chain Levels in Definite Subtypes of Disease 157
1st International Workshop on Clinical trial readiness for sarcoglycanopathies 15-16 November 2016, Evry, France 157
Collagen VI is required for the structural and functional integrity of the neuromuscular junction 156
POMT1 and POMT2 mutations in CMD patients: A multicentric Italian study 153
Aberrant Compartment Formation by HSPB2 Mislocalizes Lamin A and Compromises Nuclear Integrity and Function 150
MRI in the assessment of muscular pathology: a comparison between limb-girdle muscular dystrophies, hyaline body myopathies and myotonic dystrophies. 149
Androgen-dependent impairment of myogenesis in spinal and bulbar muscular atrophy. 149
SPP1 genotype is a determinant of disease severity in Duchenne muscular dystrophy 149
Vaccination recommendations for patients with neuromuscular disease 149
Motor neuron disease in the Padua district of Italy: an epidemiological study 148
Cognitive profile and MRI findings in limb-girdle muscular dystrophy 2I 148
Clinical and molecular characterization of limb girdle muscular dystrophy due to LAMA2 mutations. 146
New motor outcome function measures in evaluation of Late-Onset Pompe disease before and after enzyme replacement therapy 146
Survival and quality of life after tracheostomy for acute respiratory failure in patients with amyotrophic lateral sclerosis 146
The m.3243A>G mitochondrial DNA mutation and related phenotypes. A matter of gender? 144
LGMD2E patients risk developing dilated cardiomyopathy 144
X-inactivation pattern in multiple tissues from two Leber's hereditary optic neuropathy (LHON) patients 143
No effect of AR polyG polymorphism on spinal and bulbar muscular atrophy phenotype 143
Frequency of LGMD gene mutations in Italian patients with distinct clinical phenotypes 143
Reliability of the Performance of Upper Limb assessment in Duchenne muscular dystrophy. 142
24 month longitudinal data in ambulant boys with duchenne muscular dystrophy. 142
A mobile app for patients with Pompe disease and its possible clinical applications 142
Cardiac involvement in Becker muscular dystrophy 141
The italian limb girdle muscular dystrophy registry: Relative frequency, clinical features, and differential diagnosis 141
The role of AR polyQ tract in male breast carcinoma: lesson from an SBMA case 140
Targeted gene panel screening is an effective tool to identify undiagnosed late onset Pompe disease 140
Myoclonus in mitochondrial disorders. 139
Enzyme replacement therapy improves respiratory outcomes in patients with late-onset type II glycogenosis and high ventilator dependency 139
MYH7 gene mutation in myosin storage myopathy and scapulo-peroneal myopathy 138
A checklist for clinical trials in rare disease: Obstacles and anticipatory actions-lessons learned from the FOR-DMD trial 138
Insights into the genetic epidemiology of SBMA: prevalence estimation and multiple founder haplotypes in the Veneto Italian region. 138
Ablation of collagen VI leads to the release of platelets with altered function 138
Clinical and molecular study in a long-surviving patient with MLASA syndrome due to novel PUS1 mutations 135
Right hemisphere dysfunction and emotional processing in ALS: an fMRI study 135
Reliability of the North Star Ambulatory Assessment in a multicentric setting 134
Teaching an old molecule new tricks: Drug repositioning for duchenne muscular dystrophy 134
The clinical spectrum of CASQ1-related myopathy 133
Assessment of patients with idiopathic inflammatory myopathies and isolated creatin-kinase elevation 132
Gene expression profiling in dysferlinopathies using a dedicated muscle microarray 132
A pilot trial with clenbuterol in amyotrophic lateral sclerosis 131
P. 5.7 Limb-girdle muscular dystrophy type 2E: Clinical, genetic and histopathological features of 27 European patients 130
Sphingomonas paucimobilis associated with localised calf myositis 130
Neuropsychological and endocrinological study in myotonic dystrophy type 1 130
Duchenne muscular dystrophy and myotonic dystrophy in the same patient. 130
Clinical expression of facioscapulohumeral muscular dystrophy in carriers of 1-3 D4Z4 reduced alleles: Experience of the FSHD Italian National Registry 130
Safety and efficacy of edaravone compared to historical controls in patients with amyotrophic lateral sclerosis from North-Eastern Italy 130
Deflazacort in Duchenne dystrophy: study of long term effect 128
Duchenne phenotype with in-frame deletion removing major portion of dystrophin rod: threshold effect for deletion size? 127
LOPED study: Looking for an early diagnosis in a late-onset Pompe disease high-risk population 127
Cerebellar ataxia and coenzyme Q10 deficiency 126
Prevention of extubation failure in high-risk patients with neuromuscular disease 126
LMNA-associated myopathies: the Italian experience in a large cohort of patients 126
Spinal and bulbar muscular atrophy: skeletal muscle pathology in male patients and heterozygous females. 126
Epidemiology of ALS in Padova district, Italy, from 1992 to 2005 126
A novel clinical tool to classify facioscapulohumeral muscular dystrophy phenotypes 125
Memory deficits and retrieval processes in ALS 124
CAG repeat length in androgen receptor gene is not associated with amyotrophic lateral sclerosis. 124
Validation of the Italian version of the SBMA Functional Rating Scale as outcome measure 124
A genome-wide association meta-analysis identifies a novel locus at 17q11.2 associated with sporadic amyotrophic lateral sclerosis. 124
TDP-43 in skeletal muscle of patients affected with amyotrophic lateral sclerosis 123
Telethon Network of Genetic Biobanks: a key service for diagnosis and research on rare diseases. 123
SERCA1 protein expression in muscle of patients with Brody disease and Brody syndrome and in cultured human muscle fibers. 123
Redefining phenotypes associated with mitochondrial DNA single deletion 123
Becker muscular dystrophy due to an intronic splicing mutation inducing a dual dystrophin transcript 123
Neutral Lipid Storage Diseases: clinical/genetic features and natural history in a large cohort of Italian patients 123
Congenital muscular dystrophies with cognitive impairment A population study 123
Antisense-Induced Messenger Depletion Corrects a COL6A2 Dominant Mutation in Ullrich Myopathy. 123
The Role of Motor System in Mental Rotation: New Insights from Myotonic Dystrophy Type 1 123
Association Study of Exon Variants in the NF-κB and TGFβ Pathways Identifies CD40 as a Modifier of Duchenne Muscular Dystrophy 123
Dystrophinopathies 122
A novel laminin alpha2 isoform in severe laminin alpha2 deficient congenital muscular dystrophy. 122
Totale 14.853
Salva come PNG Salva come JPEG
Categoria #
all - tutte 149.547
article - articoli 127.172
book - libri 160
conference - conferenze 0
curatela - curatele 0
other - altro 877
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.228
Totale 280.984
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.717 0 0 132 689 212 292 77 431 561 404 476 443
2021/20225.752 478 694 690 428 172 380 340 500 191 177 589 1.113
2022/20233.347 807 231 55 372 557 457 16 237 386 40 148 41
2023/20241.918 73 239 214 140 136 171 104 77 103 121 253 287
2024/20258.844 49 484 456 316 1.134 236 479 735 816 402 1.471 2.266
2025/20268.014 1.349 3.048 3.617 0 0 0 0 0 0 0 0 0
Totale 43.568